逆势加仓，资金涌入这一方向

Group 1 - The overall market saw active trading in broad-based products, with A500ETF (159361) and other ETFs tracking the CSI A500 index achieving a total trading volume exceeding 130 billion yuan [1][4][5] - The Hang Seng Index rose by 1.26% last week, with the innovative drug sector in Hong Kong performing particularly well, as the Hang Seng Innovative Drug ETF (159316) saw its underlying index increase by over 8% [2][3] - The technology sector experienced a pullback, but ETFs focused on technology themes attracted significant capital inflows, with the STAR 50 Index seeing a net inflow of 2.3 billion yuan [7][8] Group 2 - The trading volume for various ETFs was notable, with the Hong Kong Securities ETF (513090) leading the market with over 48 billion yuan in trading volume, followed by A500ETF (159361) and the ChiNext ETF (159915) [5][6] - The Hang Seng Innovative Drug ETF (159316) and other ETFs tracking the Hong Kong pharmaceutical sector saw cumulative gains of around 7% last week [3][4] - The market outlook remains positive, with expectations of continued structural recovery supported by economic resilience and favorable policies, indicating that A-shares may maintain a strong performance [10]